Sunshield Reappoints Cyrus Poonevala as Independent Director

4 min read     Updated on 13 May 2026, 03:09 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Sunshield Chemicals Limited's Board has approved the reappointment of Mr. Cyrus Poonevala as an Independent Director for a second five-year term starting January 15, 2027, pending shareholder approval at the upcoming AGM.

powered bylight_fuzz_icon
40209843

*this image is generated using AI for illustrative purposes only.

Sunshield Chemicals Limited announced that its Board of Directors has approved the reappointment of Mr. Cyrus Poonevala as an Independent Director. The decision was taken during a Board meeting held on May 13, 2026, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. The reappointment is based on the recommendation of the company's Nomination and Remuneration Committee.

Mr. Poonevala has been reappointed for a second term of five years, effective from January 15, 2027, until January 14, 2032. This appointment is subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the company. Mr. Poonevala was initially appointed for a term ending on January 14, 2027.

Reappointment Details Particulars
Director Name Mr. Cyrus Poonevala
DIN 09420865
New Term Start Date January 15, 2027
New Term End Date January 14, 2032
Approval Status Subject to Shareholder Approval at AGM

Mr. Cyrus Poonevala is an experienced Aircraft Engineer with over 30 years of experience in the aviation industry, with a specific focus on maintenance. The company stated that his experience enables him to provide balanced guidance and contribute to the Board in matters relating to operations, risk oversight, and governance. He is not related to any of the existing Directors of the company and is not debarred from holding the office of Director by virtue of any SEBI order or any other authority.

Historical Stock Returns for Sunshield Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.40%+5.18%+16.97%-9.26%+16.97%+243.60%

With borrowings fully repaid and a debt-free balance sheet, how does Sunshield Chemicals plan to deploy its strengthened equity base for future capacity expansion or acquisitions?

Given the significant margin improvement in FY26, what are the key product segments or export markets driving profitability, and can this momentum be sustained amid global specialty chemicals competition?

Will the conservative dividend payout of ₹3 per share (roughly 8% of EPS) signal a shift toward reinvestment-led growth, and could shareholders expect higher dividends as cash generation improves?

Sunshield Chemicals Receives Credit Rating Upgrade from India Ratings

2 min read     Updated on 31 Mar 2026, 01:05 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

India Ratings affirmed Sunshield Chemicals' long-term rating at IND BBB+/Stable and upgraded short-term rating to IND A2+ for Rs. 45.00 crore bank facilities. The upgrade reflects improved financial flexibility from a INR1,299 million rights issue in FY26 used to repay all term debt. Revenue grew 29.1% to INR3,657.95 million in FY25, though EBITDA margin declined to 9.23% from competitive pressures and raw material volatility.

powered bylight_fuzz_icon
36444907

*this image is generated using AI for illustrative purposes only.

Sunshield chemicals has received a credit rating upgrade from India Ratings and Research (Ind-Ra), which affirmed the company's long-term rating at 'IND BBB+' with a Stable Outlook while upgrading the short-term rating to 'IND A2+' from 'IND A2'. The rating action covers bank facilities worth Rs. 45.00 crores, reduced from the previous Rs. 100.00 crores.

Rating Details and Financial Impact

The upgrade reflects significant improvement in the company's financial flexibility following strategic debt management initiatives. In FY26, Sunshield Chemicals raised INR1,299 million through a rights issue, utilizing the proceeds to fully repay all term debt and unsecured loans from the parent company.

Facility Type: Amount Rating Action
Bank Loan Facilities: Rs. 45.00 crores IND BBB+/Stable/IND A2+ Long-term affirmed; short-term upgraded

Key Financial Performance Metrics

The company's financial performance shows mixed trends with revenue growth offset by margin pressures. Revenue increased to INR3,657.95 million in FY25 from INR2,833.75 million in FY24, representing significant growth driven by capacity expansion and volume increases.

Financial Metric: FY25 FY24 Change
Revenue (INR million): 3,657.95 2,833.75 +29.1%
EBITDA (INR million): 337.75 404.33 -16.5%
EBITDA Margin (%): 9.23 14.27 -5.04pp
Interest Coverage (x): 3.71 5.19 -1.48x
Net Leverage (x): 2.89 2.11 +0.78x

Operational Strengths and Market Position

Sunshield Chemicals benefits from experienced promoter support through Indus Petrochem Limited's 62.36% holding, bringing over 25 years of sectoral expertise. The company operates a diversified portfolio serving multiple end-use sectors including metal treatment, wire enamels, PVC stabilizers, and various industrial applications across India and international markets.

The company expanded its installed capacity to 25,231MTPA in FY25 from 18,067MTPA in FY24, with sales volumes increasing by 29% year-on-year despite competitive pressures on realizations. In 9MFY26, the company recorded revenues of INR3,312.40 million with EBITDA margin improving to 10.78%.

Risk Factors and Market Challenges

Despite positive developments, the company faces several challenges that impact its operational performance:

  • Forex Risk: Exposure to foreign exchange fluctuations from raw material imports and product exports, with no formal hedging policy
  • Market Competition: Intense pressure from Chinese suppliers with aggressive pricing strategies
  • Demand Volatility: Prolonged weakness in global specialty chemical demand affecting overall market sentiment

Liquidity and Working Capital Management

The company maintains adequate liquidity with month-end average utilization of fund-based and non-fund-based limits at 59% for the 12 months ended January 2026. The net working capital cycle improved to 75 days in FY25 from 83 days in FY24, though it lengthened marginally to 87 days in 9MFY26.

Cash flow from operations strengthened to INR389 million in FY25 from INR342 million in FY24, supported by favorable working capital movements. The company maintains cash and cash equivalents of INR28 million with no upcoming term-debt repayment obligations.

Historical Stock Returns for Sunshield Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.40%+5.18%+16.97%-9.26%+16.97%+243.60%

How will Sunshield Chemicals address the ongoing margin pressure from Chinese competitors while maintaining its market share in the specialty chemicals sector?

What specific strategies might the company implement to improve its EBITDA margins back to FY24 levels of 14.27% given the current competitive landscape?

Will Sunshield Chemicals consider establishing a formal forex hedging policy to mitigate currency risks from raw material imports and export revenues?

More News on Sunshield Chemicals

1 Year Returns:+16.97%